JPS56125361A - Azetidinone compound - Google Patents

Azetidinone compound

Info

Publication number
JPS56125361A
JPS56125361A JP2805980A JP2805980A JPS56125361A JP S56125361 A JPS56125361 A JP S56125361A JP 2805980 A JP2805980 A JP 2805980A JP 2805980 A JP2805980 A JP 2805980A JP S56125361 A JPS56125361 A JP S56125361A
Authority
JP
Japan
Prior art keywords
formula
compound
solvent
azido
benzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2805980A
Other languages
Japanese (ja)
Inventor
Iwao Oshima
Shigeki Suga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Priority to JP2805980A priority Critical patent/JPS56125361A/en
Publication of JPS56125361A publication Critical patent/JPS56125361A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:Compounds of formula I', formula I" and I'''(Ar is aromatic group; R1 is H, alkyl, or aryl; R2 is alkyl or aryl; X' is benzyloxy or azido; X" is OH or amino; X''' is acylamino).
EXAMPLE: 1-(1-Methoxycarbonylbenzyl)-3-azido-4-phenylazetidin-2-one.
USE: Raw material for the preparation of dipeptide.
PROCESS: Reaction of a Schiff base of formula II with a compound of formula III (Y is halogen or OH) in a solvent such as benzene, in the presence of a tert-amine such as triethylamine at -78W+100°C, affords a compound of formula I', whih can be converted to a compound of formula I" by the hydrogenative decomposition in a solvent such as methanol, in the presence of a catalyst such as Pd black at room temp. W150°C. A compound of the formula I" can be prepared by reacting a compound of formula I" wherein X" is amino with an acid chloride or an acid anhydride in a solvent such as benzene at -30°C Wroom temp.
COPYRIGHT: (C)1981,JPO&Japio
JP2805980A 1980-03-07 1980-03-07 Azetidinone compound Pending JPS56125361A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2805980A JPS56125361A (en) 1980-03-07 1980-03-07 Azetidinone compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2805980A JPS56125361A (en) 1980-03-07 1980-03-07 Azetidinone compound

Publications (1)

Publication Number Publication Date
JPS56125361A true JPS56125361A (en) 1981-10-01

Family

ID=12238181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2805980A Pending JPS56125361A (en) 1980-03-07 1980-03-07 Azetidinone compound

Country Status (1)

Country Link
JP (1) JPS56125361A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953465A (en) * 1982-08-19 1984-03-28 エフ・ホフマン―ラ ロシユ アーゲー Beta-lactams
JPS6036458A (en) * 1983-08-08 1985-02-25 Sumitomo Chem Co Ltd Preparation of beta-lactam derivative
JPH029862A (en) * 1988-06-27 1990-01-12 Sankyo Co Ltd Production of azetidinone derivative
WO2007011878A2 (en) * 2005-07-19 2007-01-25 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
US9376424B2 (en) 2010-07-01 2016-06-28 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
US9597314B2 (en) 2005-03-22 2017-03-21 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
US9802925B2 (en) 2014-03-28 2017-10-31 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
US11628160B2 (en) 2017-09-15 2023-04-18 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645085A1 (en) * 1975-10-06 1977-04-14 Fujisawa Pharmaceutical Co 2-ACETIDINONE COMPOUNDS AND METHOD FOR THEIR PRODUCTION
US4140688A (en) * 1978-04-03 1979-02-20 Smithkline Corporation Tricyclic (azeto-isoquinoline) β-lactams

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645085A1 (en) * 1975-10-06 1977-04-14 Fujisawa Pharmaceutical Co 2-ACETIDINONE COMPOUNDS AND METHOD FOR THEIR PRODUCTION
US4140688A (en) * 1978-04-03 1979-02-20 Smithkline Corporation Tricyclic (azeto-isoquinoline) β-lactams

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953465A (en) * 1982-08-19 1984-03-28 エフ・ホフマン―ラ ロシユ アーゲー Beta-lactams
JPH0587515B2 (en) * 1982-08-19 1993-12-16 Hoffmann La Roche
JPS6036458A (en) * 1983-08-08 1985-02-25 Sumitomo Chem Co Ltd Preparation of beta-lactam derivative
JPH029862A (en) * 1988-06-27 1990-01-12 Sankyo Co Ltd Production of azetidinone derivative
US9597314B2 (en) 2005-03-22 2017-03-21 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
US8426400B2 (en) 2005-07-19 2013-04-23 Azevan Pharmaceuticals, Inc. β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
WO2007011878A2 (en) * 2005-07-19 2007-01-25 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
US8048874B2 (en) 2005-07-19 2011-11-01 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
WO2007011878A3 (en) * 2005-07-19 2007-09-07 Azevan Pharmaceuticals Inc Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
AU2006270039B2 (en) * 2005-07-19 2013-07-04 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
JP2013151520A (en) * 2005-07-19 2013-08-08 Azevan Pharmaceuticals Inc Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist
KR101523776B1 (en) * 2005-07-19 2015-05-28 아제반 파마슈티칼스, 인코퍼레이티드 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
JP2009502788A (en) * 2005-07-19 2009-01-29 アゼヴァン ファーマスーティカルズ,インコーポレイテッド Beta-lactamphenylalanine, cysteine, and serine vasopressin antagonist
US9376424B2 (en) 2010-07-01 2016-06-28 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
US9987265B2 (en) 2010-07-01 2018-06-05 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
US9802925B2 (en) 2014-03-28 2017-10-31 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
US10364236B2 (en) 2014-03-28 2019-07-30 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
US11319306B2 (en) 2014-03-28 2022-05-03 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
US11628160B2 (en) 2017-09-15 2023-04-18 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury

Similar Documents

Publication Publication Date Title
JPS56125361A (en) Azetidinone compound
ES8300735A1 (en) Phenylalkanoic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
JPS56128778A (en) Preparation of alkylene carbonate
JPS5527147A (en) Preparation of carboxylic acid having aryl substituent
JPS55130952A (en) 1,1,3,5-substituted biuret compound
ES8307236A1 (en) Process for the preparation of a furan derivative.
JPS5473758A (en) Asymmetric synthesis of chrysanthemumic acid derivative ester
JPS5749614A (en) Preparation of organic carbonates
JPS5645454A (en) Cyclohexanecarboxylic acid derivative and its preparation
JPS5731682A (en) Preparation of alkylene carbonate
JPS56125360A (en) Beta-lactam compound
JPS5627648A (en) Preparation of filler for chromatography
JPS5748971A (en) Novel alkylimidazole derivative
JPS5742678A (en) Preparation of 2-oxazolidinone compound
JPS57212172A (en) Preparation of cyanuric halide derivative
JPS56123964A (en) 1- n-benzyl-o- 2,6-dichloroanilino phenyl -2-methylsulfinyl- 2-methylthioethylene
JPS5592363A (en) New 2-azetidinone derivative
JPS57159763A (en) Synthesis of antibiotic substance sf-2080c and d substance
JPS56147769A (en) Preparation of n-substituted piperidinol derivative
JPS5629547A (en) Preparation of 1-aryloxy-3-isopropylamino-2-propanol
JPS5659727A (en) Preparation of substituted phenol
JPS5679661A (en) Preparation of alpha-chlorohydrocinnamnitrile
JPS57200338A (en) Preparation of amide
JPS55154933A (en) Preparation of 3-benzoylbenzaldehyde
JPS56123972A (en) Preparation of 1,3-dialkyl-4-benzoyl-5-hydroxypyrazole compound